APRE · Aprea Therapeutics, Inc. · Documents
Market Cap
$6.56M
Shares
12.59M
Volume · Oct 20
366.95K
Avg daily vol (3M)
288.61K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-11-08 | — | |
| 8-K | — | 2021-10-15 | 2021-10-13 | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| 8-K | — | 2021-08-12 | 2021-08-11 | |
| 8-K | — | 2021-08-06 | 2021-08-04 | |
| 8-K | — | 2021-06-10 | 2021-06-09 | |
| 8-K | — | 2021-05-06 | — | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| DEF 14A | — | 2021-04-28 | 2021-06-09 | |
| 10-K | — | 2021-03-16 | 2020-12-31 | |
| 8-K | — | 2021-03-16 | — | |
| 8-K | — | 2021-01-12 | — | |
| 8-K | — | 2020-12-28 | — | |
| 10-Q | — | 2020-11-06 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-09-29 | 2020-09-28 | |
| 8-K | — | 2020-09-18 | 2020-09-16 | |
| 8-K | — | 2020-08-11 | — | |
| 10-Q | — | 2020-08-11 | 2020-06-30 | |
| 8-K | — | 2020-06-29 | 2020-06-26 | |
| 10-Q | — | 2020-05-15 | 2020-03-31 | |
| 8-K | — | 2020-05-15 | — | |
| DEF 14A | — | 2020-04-29 | 2020-06-26 | |
| 8-K | — | 2020-04-03 | — | |
| 10-K | — | 2020-03-27 | 2019-12-31 | |
| 8-K | — | 2020-03-26 | — | |
| 8-K | — | 2020-01-13 | — |
Showing 101–127 of 127 filings